论文部分内容阅读
一、三磷酸腺苷(ATP)纠治阵发性室上性心动过速(PSVT)的评价早在1947年Somlo E就已报道静注三磷酸腺苷可以终止阵发性室上性心动过速。1955年Somlo E报道静注ATP20mg终止PSVT取得了满意的疗效,肌注ATP时无效。Komor K与Galas ZS报道肌注ATP10—70mg治疗52例PSVT全部有效,未发现有长远副作用。此后30年来,这一
First, adenosine triphosphate (ATP) to evaluate the evaluation of paroxysmal supraventricular tachycardia (PSVT) As early as 1947, Somlo E has reported intravenous adenosine triphosphate can terminate paroxysmal supraventricular tachycardia. 1955 Somlo E reported that intravenous injection of ATP20mg termination of PSVT achieved satisfactory results, intramuscular injection of ATP is invalid. Komor K and Galas ZS reported that intramuscular injection of 10-70 mg ATP was effective in 52 patients with PSVT and no long-term side effects were found. After 30 years, this one